These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38819125)

  • 1. Augmentation Therapy Decreases Platelet-Neutrophil Aggregates in Alpha-1 Antitrypsin Deficiency.
    Lacey N; Teo JYQ; Baird R; Forde L; Hawkins P; McEnery T; Lee MQ; Hoo MCS; Gogoi D; Reeves EP
    Am J Respir Cell Mol Biol; 2024 Jun; 70(6):524-527. PubMed ID: 38819125
    [No Abstract]   [Full Text] [Related]  

  • 2. α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8.
    Bergin DA; Reeves EP; Meleady P; Henry M; McElvaney OJ; Carroll TP; Condron C; Chotirmall SH; Clynes M; O'Neill SJ; McElvaney NG
    J Clin Invest; 2010 Dec; 120(12):4236-50. PubMed ID: 21060150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.
    McEnery T; White MM; Gogoi D; Coleman O; Bergin D; Jundi B; Flannery R; Alsaif FAT; Landers SA; Casey M; Dunlea D; Meleady P; McElvaney NG; Reeves EP
    Am J Respir Cell Mol Biol; 2022 Jul; 67(1):76-88. PubMed ID: 35507773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA; Stoller JK
    Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.
    Schmid ST; Koepke J; Dresel M; Hattesohl A; Frenzel E; Perez J; Lomas DA; Miranda E; Greulich T; Noeske S; Wencker M; Teschler H; Vogelmeier C; Janciauskiene S; Koczulla AR
    Int J Chron Obstruct Pulmon Dis; 2012; 7():687-96. PubMed ID: 23055718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency.
    Mueller C; Gernoux G; Gruntman AM; Borel F; Reeves EP; Calcedo R; Rouhani FN; Yachnis A; Humphries M; Campbell-Thompson M; Messina L; Chulay JD; Trapnell B; Wilson JM; McElvaney NG; Flotte TR
    Mol Ther; 2017 Jun; 25(6):1387-1394. PubMed ID: 28408179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
    Hurley K; Lacey N; O'Dwyer CA; Bergin DA; McElvaney OJ; O'Brien ME; McElvaney OF; Reeves EP; McElvaney NG
    J Immunol; 2014 Oct; 193(8):3978-91. PubMed ID: 25217166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.
    Hurley K; Reeves EP; Carroll TP; McElvaney NG
    Expert Rev Respir Med; 2016 Feb; 10(2):207-22. PubMed ID: 26634397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema.
    Traclet J; Delaval P; Terrioux P; Mornex JF
    Rev Mal Respir; 2015 Apr; 32(4):435-46. PubMed ID: 25908241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation therapy in alpha(1)-antitrypsin deficiency.
    Burdon JG; Brenton S; Ayad M; Knight K
    Chest; 2001 Aug; 120(2):687. PubMed ID: 11502686
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation treatment for α1 antitrypsin deficiency.
    Crystal RG
    Lancet; 2015 Jul; 386(9991):318-20. PubMed ID: 26026937
    [No Abstract]   [Full Text] [Related]  

  • 15. alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding.
    Stoller JK; Aboussouan LS
    Thorax; 2004 Aug; 59(8):708-12. PubMed ID: 15282394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gained.
    Sclar DA; Evans MA; Robison LM; Skaer TL
    Clin Drug Investig; 2012 May; 32(5):353-60. PubMed ID: 22480280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key current clinical issues in alpha-1 antitrypsin deficiency.
    Stoller JK
    Respir Care; 2003 Dec; 48(12):1216-21; discussion 1221-4. PubMed ID: 14651762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.
    Hawkins P; Sya J; Hup NK; Murphy MP; McElvaney NG; Reeves EP
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441020
    [No Abstract]   [Full Text] [Related]  

  • 19. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
    O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
    J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Sandhaus RA
    COPD; 2009 Jun; 6(3):147-8. PubMed ID: 19811367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.